- Open Access
Facilitation of the inhibitory transmission by gastrin-releasing peptide in the anterior cingulate cortex
© Cao et al; licensee BioMed Central Ltd. 2010
- Received: 23 July 2010
- Accepted: 13 September 2010
- Published: 13 September 2010
Gastrin-releasing peptide (GRP) has been proposed as a peptidergic molecule for behavioral fear and itching. Immunohistochemistry and in situ hybridization studies have shown that GRP and GRP receptor are widely distributed in forebrain areas. Less information is available for the functional action for GRP in the prefrontal cortex including the anterior cingulate cortex (ACC). Here we used whole-cell patch-clamp recording technique to study the modulation of synaptic transmission by GRP in the ACC. We found that GRP increased the frequency of sIPSCs recorded while had no significant effect on sEPSCs in ACC pyramidal neurons. The facilitatory effect of GRP on sIPSCs was blocked by the GRP receptor antagonist, RC3095. In the presence of TTX, however, GRP had no effect on the mIPSCs. Therefore, activation of GRP receptor may facilitate the excitation of the interneurons and enhanced spontaneous GABAergic, but not glutamatergic neurotransmission. Similar results on GRP modulation of GABAergic transmission were observed in the insular cortex and amygdala, suggesting a general possible effect of GRP on cortical inhibitory transmission. Our results suggest that GRP receptor is an important regulator of inhibitory circuits in forebrain areas.
- Anterior Cingulate Cortex
- Pyramidal Neuron
- Insular Cortex
- Gaba Release
- GABAergic Transmission
Gastrin-releasing peptide (GRP) is a mammalian analogue of bombesin (BB), a 14 amino acid-containing peptide first isolated from the skin of the frog Bombina bombina [1, 2]. Anatomic studies have shown that GRP and its receptors are widely distributed in the central nervous system, in addition to the gastrointestinal (GI) tract [2–10]. GRP has been implicated in many physiological and pathological conditions such as the regulation of the circadian rhythm, exocrine and endocrine secretions, smooth muscle contraction, inflammation, feeding, fear and behavioral itch [11–17].
Recent studies on GRP in sensory systems have triggered new interests on GRP. At the level of the spinal cord, it has been reported that GRP may serve as a selective signaling transmitters for itching sensation [14, 15]. In the amygdala, it has been reported that GRP may contribute to regulation of neuronal excitability, and contribute to behavioral fear . Although it has been known that GRP is distributed in cortical areas, less is known about the possible modulatory effects of GRP on cortical circuits. The anterior cingulate cortex (ACC), a key structure of the prefrontal cortex, plays an established role in learning and memory, drug addiction, and chronic pain [19–22]. In the present study, we have investigated the effects of GRP on both excitatory and inhibitory transmission in the ACC. Our results show that the GRP selectively facilitate GABAergic but not glutamatergic neurotransmission. The facilitation may result from the GRP-induced inward current and firing of GABAergic interneurons in the ACC.
Adult male C57BL/6 mice were purchased from Charles River (6-10 weeks old). All mice were maintained on a 12 h light/dark cycle with food and water provided ad libitum. All protocols used were approved by The Animal Care and use Committee at the University of Toronto and conform to NIH guidelines.
Whole-cell Patch Clamp Recordings
Adult male mice were anesthetized with 1-2% halothane and decapitated. Coronal slices (300 μm) containing the ACC, amygdala or insular cortex will be prepared using routine methods used in our laboratory [23, 24]. Slices were then transferred to a submerged recovery chamber with oxygenated (95% O2 and 5% CO2) ACSF at room temperature. After a one-hour recovery period, slices were placed in a recording chamber on the stage of an Axioskop 2FS microscope (Zeiss) equipped with infrared DIC optics for visually-guided whole cell patch clamp recordings. Pyramidal neurons or interneurons in Layer II-III in the ACC were recorded with an Axon 200B amplifier (Molecular device, Union city, CA). Recording electrodes (2-5 M) contained an internal solution composed of (in mM): Kgluconate, 120; NaCl, 5; MgCl2 1; EGTA, 0.5; Mg-ATP, 2; Na3GTP, 0.1; HEPES, 10; pH 7.2; 280-300 mOsmol. The membrane potentials were held at -70 mV throughout all experiments. When recording GABAA receptor-mediated currents, K-gluconate was replaced by Cs-MeSO3 and a holding potential of 10 mV. Spontaneous EPSCs were recorded in the presence of GABAA receptor antagonist, picrotoxin (100 μM) and spontaneous IPSCs were recorded in the presence of a NMDA receptor antagonist, AP5 (100 μM) and a non-NMDA receptor antagonist, CNQX (20 μM). GRP and its receptor antagonist RC3095 were purchased from Sigma. To examine the mIPSCs, TTX (1 μM) was bath-applied in the perfusion solution. The sIPSCs/mIPSCs were analyzed with the Mini Analysis Program v5.2.4 (Synaptosoft Inc., Decatur, GA). Access resistance was 15-30MO and monitored throughout the experiments. Data were discarded if access resistance changed > 15% during an experiment. Signals were filtered at 1 kHz, digitized at 10 kHz.
Passive and Active Membrane Properties
Off-line analysis was performed using Clampfit version 9 (Axon Instruments). Resting membrane potential (RMP) was the low-pass readout of the electrode amplifier and was not corrected for liquid junction potential (~12 mV) after terminating the recording. The membrane potential was measured immediately after establishing the whole-cell configuration. Only neurons that had a resting membrane potential more negative than -60 mV were further investigated. Conductance was determined from the linear slope (between -60 mV to -80 mV) of the current-voltage (I-V; Vhold = -70 mV) relationships. Action potentials (APs) were detected in response to suprathreshold current injections from a holding potential around -70 mV. Depolarizing currents of 5~200 pA (400-ms duration) were delivered in increments of 5 pA until an AP was evoked. The rheobase was defined as the minimum current required to evoke an action potential. The AP voltage threshold (Vthreshold) was defined as the first point on the rising phase of the spike at which the change in voltage exceeded 50 mV/ms. The spike amplitude was quantified as the difference between the Vthreshold and the peak voltage. The spike width was measured at 1/2 of the total spike amplitude (measured from the Vthreshold level). The amplitude of the afterhyperpolarization (AHP) was estimated as the difference between the Vthreshold and the peak of AHP.
Mice were deeply anesthetized with halothane and perfused transcardially with 50-100 ml saline followed by 150-500 ml of cold 0.1 M phosphate buffer (PB) containing 4% paraformaldehyde. Brains were removed and post-fixed in 4% paraformaldehyde/PBS and then will be placed in 30% sucrose in 0.2 M PBS, embedded in the OCT compound and frozen. Coronal sections (30 μM thickness) were cut using a cryostat. For dual fluorescent immunohistochemistry, sections were incubated overnight with anti-GRPR (1:50; rabbit polycolonal, Santa Cruz Biotecnology) and anti-GAD67 (1:300; mouse monoclonal, Chemicon) antibodies at 4°C. Sections were then be washed 3 times with PBS 0.1 M and incubated for 2 hours with anti Mouse-FITC and rabbit-rhodamine conjugated secondary antibodies (1:200; Chemicon). Images of the ACC areas of at 0.7-μm intervals with 20× lens were obtained with Bio-Rad Laboratories MRC 1000 laser-scanning confocal fluorescent imaging system.
Results were expressed as mean ± standard error of the mean (S. E. M.). Statistical comparisons were performed with the use of one- or two-way analysis of variance (ANOVA) with the post-hoc Scheffe F-test in immunocytochemical experiments. Analysis of mIPSCs/sEPSCs was performed with cumulative probability plots and was compared using the Kolmogorov-Smirnov (K-S) test for significant differences. In all cases, P < 0.05 was considered statistically significant.
The expression of GRP and GRP receptors in the ACC
Morphological and electrophysiological properties of interneurons and pyramidal neurons in the ACC
Basic electrophysiological properties of ACC pyramidal and inhibitory neurons
Number of neurons tested
Resting membrane potential, mV
-73.0 ± 1.0
-61.4 ± 1.9
P < 0.001
Input resistance, M Ω
124.3 ± 6.3
332.4 ± 48.1
P < 0.001
Rheobase current, pA
95.7 ± 7.3
56.8 ± 11.8
P < 0.01
Action potential threshold, mV
-35.4 ± 0.4
-43.0 ± 0.9
P < 0.001
Action potential amplitude, mV
93.8 ± 0.8
88.2 ± 2.6
P < 0.01
Action potential half-width, ms
1.50 ± 0.03
1.00 ± 0.05
P < 0.001
Amplitude of after-hyperpolarization, ms
-6.9 ± 0.3
-24.8 ± 2.5
P < 0.001
GRP induced inward currents in interneurons but small or undetectable currents in pyramidal neurons
To examine the function of GRP receptor in the ACC, GRP was applied through bath solution and the responses of pyramidal neurons and interneurons were recorded. At holding potential of -70 mV a short application of GRP (300 nM) induced a slowly developing inward current (peak 16.9 ± 1.8 pA) that recovered slowly over 10 min (n = 8/10 interneurons). However, in pyramidal neurons there was undetectable currents upon GRP application (300 nM, n = 7). In the presence of GRP receptor antagonist, RC3095 (3 μM), the effect of GRP induced inward current in interneurons (n = 7) was completely blocked (data not shown). These results indicate that GRP selectively activated interneuronal GRP receptor in the ACC.
Activation of GRP receptors enhances spontaneous GABAergic, but not glutamatergic transmission
Increase of GABA release by GRP is action potential dependent
Activation of GRP receptor also increased the frequency of sIPSCs in pyramidal neurons in the basolateral anygdala (BLA) and insular cortex (IC)
In the present study, we used whole-cell patch-clamp recording to study the actions of GRP on ACC neurons in adult mice. Our results provide strong electrophysiological evidence that GRP receptor facilitates inhibitory GABA release in the ACC. Activation of GRP receptor preferentially modulated GABAergic, but not glutamatergic transmission. Furthermore, somatodendritic GRP receptor mediated action potential-dependent GABA release in the ACC occurred in other regions, such as the BLA and IC, indicating a general role of GRP receptor in the modulation of cortical GABAergic transmission.
How GRP facilitate GABAergic transmission and modulate the neuronal circuits in the ACC? Several lines of evidence in the present study suggest that GRP acts on somatodendritic GRP receptor in GABAergic neurons to induce neuronal firing and GABA release in interneurons, thereby decreasing the excitability of pyramidal neurons. Bath application of GRP facilitated sIPSC frequency in a concentration- dependent manner, but GRP had little effect on either frequency or amplitude of mIPSCs. These results are similar to the modulatory effects of the GRP/GRP receptor system on GABAergic transmission in lateral amygdala and hippocampus [18, 26]. Interestingly, in the present study, although ACC pyramidal neurons are shown to express GRP receptors, we found little direct effect of GRP on these cell bodies nor on the frequency and amplitude of sEPSC. We cannot completely rule out other possible modulation of GRP on excitatory transmission that cannot be revealed in the present studies. Future studies are clearly needed in further investigating the roles of GRP.
ACC neurons are multi-functional and play important roles in a wide variety of behavioral functions, including sensory pain, memory, emotional and cognitive functions [19–22, 27, 28]. Glutamate is the fast excitatory transmitter  and GABA is the inhibitory transmitter in the ACC . A balance between excitatory and inhibitory transmission is critical for many brain functions. Previous reports show that the GRP in the amygdala is inovolved in behavioral fear [18, 31–36]. In addition to the amygdala, recent studies show that lesion of the ACC produced an impairment in trace fear conditioning  and electrical stimulation of the ACC induced fear memory . The results of the present study show that GRP may facilitate the GABAergic transmission in the ACC synapses, indicating that GRP may contribute to behavioral fear or trace fear memory by affecting inhibitory transmission within the ACC.
GRP has been implicated in mediation the itch sensation in the spinal cord [14, 15]. The possible roles of GRP within the ACC in behavioral itching have not been investigated. Furthermore, a recent work in the spinal dorsal horn suggests that alteration of inhibitory transmission in the spinal cord is important for behavioral itching . It is possible that GRP may also affect spinal inhibitory transmission, in addition to act as a potential transmitter for itch from the periphery. Future studies are clearly needed in the spinal cord. Furthermore, direct evidence for GRP to act as a neurotransmitter for itching is still lacking. In human studies, ACC and IC have been shown to be involved in itch processing [40–45]. Future studies are required to address whether the modulation of GRP in the ACC inhibitory circuit would contribution to itch sensation. In summary, we report here that GRP play an important role in modulating inhibitory transmission within the ACC, IC and amygdala. It is likely that supraspinal GRP may contribute to a wide range of physiological and pathological functions, rather than act as a selective transmitter for itch as reported at the level of spinal cord.
The authors declare that they have no competing interests.
This work was supported by Grants from the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, Canada Research Chair, NeuroCanada, and CIHR operating grants (CIHR66975 and CIHR81086) (M. Z.). M.Z. is also supported by the World-Class University (WCU) program of the Ministry of Education, Science and Technology in Korea through KOSEF (R32-10142).
- Anastasi A, Erspamer V, Bucci M: Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 1971,27(2):166–167. 10.1007/BF02145873PubMedView ArticleGoogle Scholar
- Battey J, Wada E: Two distinct receptor subtypes for mammalian bombesin-like peptides. Trends Neurosci 1991,14(12):524–528. 10.1016/0166-2236(91)90005-FPubMedView ArticleGoogle Scholar
- Kamichi S, Wada E, Aoki S, Sekiguchi M, Kimura I, Wada K: Immunohistochemical localization of gastrin-releasing peptide receptor in the mouse brain. Brain Res 2005,1032(1–2):162–170. 10.1016/j.brainres.2004.10.068PubMedView ArticleGoogle Scholar
- Ladenheim EE, Jensen RT, Mantey SA, Moran TH: Distinct distributions of two bombesin receptor subtypes in the rat central nervous system. Brain Res 1992,593(2):168–178. 10.1016/0006-8993(92)91305-XPubMedView ArticleGoogle Scholar
- Moody TW, Getz R, O'Donohue TL, Rosenstein JM: Localization of receptors for bombesin-like peptides in the rat brain. Ann N Y Acad Sci 1988, 547: 114–130. 10.1111/j.1749-6632.1988.tb23880.xPubMedView ArticleGoogle Scholar
- Moody TW, O'Donohue TL, Jacobowitz DM: Biochemical localization and characterization of bombesin-like peptides in discrete regions of rat brain. Peptides 1981,2(1):75–79. 10.1016/S0196-9781(81)80014-9PubMedView ArticleGoogle Scholar
- Moran TH, Moody TW, Hostetler AM, Robinson PH, Goldrich M, McHugh PR: Distribution of bombesin binding sites in the rat gastrointestinal tract. Peptides 1988,9(3):643–649. 10.1016/0196-9781(88)90177-5PubMedView ArticleGoogle Scholar
- Panula P, Yang HY, Costa E: Neuronal location of the bombesin-like immunoreactivity in the central nervous system of the rat. Regul Pept 1982,4(5):275–283. 10.1016/0167-0115(82)90120-3PubMedView ArticleGoogle Scholar
- Wada E, Way J, Lebacq-Verheyden AM, Battey JF: Neuromedin B and gastrin-releasing peptide mRNAs are differentially distributed in the rat nervous system. J Neurosci 1990,10(9):2917–2930.PubMedGoogle Scholar
- Wada E, Way J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D, Jensen R, Battery J: cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor. Neuron 1991,6(3):421–430. 10.1016/0896-6273(91)90250-4PubMedView ArticleGoogle Scholar
- Gamble KL, Allen GC, Zhou T, McMahon DG: Gastrin-releasing peptide mediates light-like resetting of the suprachiasmatic nucleus circadian pacemaker through cAMP response element-binding protein and Per1 activation. J Neurosci 2007,27(44):12078–12087. 10.1523/JNEUROSCI.1109-07.2007PubMedView ArticleGoogle Scholar
- Petronilho F, Roesler R, Schwartsmann G, Dal Pizzol F: Gastrin-releasing peptide receptor as a molecular target for inflammatory diseases. Inflamm Allergy Drug Targets 2007,6(4):197–200. 10.2174/187152807783334319PubMedView ArticleGoogle Scholar
- Patel O, Shulkes A, Baldwin GS: Gastrin-releasing peptide and cancer. Biochim Biophys Acta 2006,1766(1):23–41.PubMedGoogle Scholar
- Sun YG, Chen ZF: A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 2007,448(7154):700–703. 10.1038/nature06029PubMedView ArticleGoogle Scholar
- Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF: Cellular basis of itch sensation. Science 2009,325(5947):1531–1534. 10.1126/science.1174868PubMedView ArticleGoogle Scholar
- Gonzalez N, Moody TW, Igarashi H, Ito T, Jensen RT: Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 2008,15(1):58–64.PubMed CentralPubMedView ArticleGoogle Scholar
- Ohki-Hamazaki H, Iwabuchi M, Maekawa F: Development and function of bombesin-like peptides and their receptors. Int J Dev Biol 2005,49(2–3):293–300. 10.1387/ijdb.041954hoPubMedView ArticleGoogle Scholar
- Shumyatsky GP, Tsvetkov E, Malleret G, Vronskaya S, Hatton M, Hampton L, Battey JF, Dulac C, Kandel ER, Bolshakov VY: Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell 2002,111(6):905–918. 10.1016/S0092-8674(02)01116-9PubMedView ArticleGoogle Scholar
- Courtney SM, Petit L, Maisog JM, Ungerleider LG, Haxby JV: An area specialized for spatial working memory in human frontal cortex. Science 1998,279(5355):1347–1351. 10.1126/science.279.5355.1347PubMedView ArticleGoogle Scholar
- Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC: Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997,277(5328):968–971. 10.1126/science.277.5328.968PubMedView ArticleGoogle Scholar
- Zhao MG, Toyoda H, Lee YS, Wu LJ, Ko SW, Zhang XH, Jia Y, Shum F, Xu H, Li BM, et al.: Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron 2005,47(6):859–872. 10.1016/j.neuron.2005.08.014PubMedView ArticleGoogle Scholar
- Zhuo M: Glutamate receptors and persistent pain: targeting forebrain NR2B subunits. Drug Discov Today 2002,7(4):259–267. 10.1016/S1359-6446(01)02138-9PubMedView ArticleGoogle Scholar
- Cao XY, Xu H, Wu LJ, Li XY, Chen T, Zhuo M: Characterization of intrinsic properties of cingulate pyramidal neurons in adult mice after nerve injury. Mol Pain 2009, 5–73. 10.1186/1744-8069-5-5Google Scholar
- Wu LJ, Ko SW, Toyoda H, Zhao MG, Xu H, Vadakkan KI, Ren M, Knifed E, Shum F, Quan J, et al.: Increased anxiety-like behavior and enhanced synaptic efficacy in the amygdala of GluR5 knockout mice. PLoS One 2007,2(1):e167. 10.1371/journal.pone.0000167PubMed CentralPubMedView ArticleGoogle Scholar
- Wu LJ, Toyoda H, Zhao MG, Lee YS, Tang J, Ko SW, Jia YH, Shum FW, Zerbinatti CV, Bu G, et al.: Upregulation of forebrain NMDA NR2B receptors contributes to behavioral sensitization after inflammation. J Neurosci 2005,25(48):11107–11116. 10.1523/JNEUROSCI.1678-05.2005PubMedView ArticleGoogle Scholar
- Lee K, Dixon AK, Gonzalez I, Stevens EB, McNulty S, Oles R, Richardson PJ, Pinnock RD, Singh L: Bombesin-like peptides depolarize rat hippocampal interneurones through interaction with subtype 2 bombesin receptors. J Physiol 1999,518(Pt 3):791–802. 10.1111/j.1469-7793.1999.0791p.xPubMed CentralPubMedView ArticleGoogle Scholar
- Zhuo M: Cortical excitation and chronic pain. Trends Neurosci 2008,31(4):199–207. 10.1016/j.tins.2008.01.003PubMedView ArticleGoogle Scholar
- Zhuo M: A synaptic model for pain: long-term potentiation in the anterior cingulate cortex. Mol Cells 2007,23(3):259–271.PubMedGoogle Scholar
- Wei F, Li P, Zhuo M: Loss of synaptic depression in mammalian anterior cingulate cortex after amputation. J Neurosci 1999,19(21):9346–9354.PubMedGoogle Scholar
- Wu LJ, Xu H, Ren M, Zhuo M: Genetic and pharmacological studies of GluR5 modulation of inhibitory synaptic transmission in the anterior cingulate cortex of adult mice. Dev Neurobiol 2007,67(2):146–157. 10.1002/dneu.20331PubMedView ArticleGoogle Scholar
- Yamada K, Santo-Yamada Y, Wada E, Wada K: Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice. Mol Psychiatry 2002,7(1):113–117. 116 10.1038/sj/mp/4000974PubMedView ArticleGoogle Scholar
- Martins MR, Reinke A, Valvassori SS, Machado RA, Quevedo J, Schwartsmann G, Roesler R: Non-associative learning and anxiety in rats treated with a single systemic administration of the gastrin-releasing peptide receptor antagonist RC-3095. Peptides 2005,26(12):2525–2529. 10.1016/j.peptides.2005.06.006PubMedView ArticleGoogle Scholar
- Roesler R, Kopschina MI, Rosa RM, Henriques JA, Souza DO, Schwartsmann G: RC-3095, a bombesin/gastrin-releasing peptide receptor antagonist, impairs aversive but not recognition memory in rats. Eur J Pharmacol 2004,486(1):35–41. 10.1016/j.ejphar.2003.12.011PubMedView ArticleGoogle Scholar
- Roesler R, Meller CA, Kopschina MI, Souza DO, Henriques JA, Schwartsmann G: Intrahippocampal infusion of the bombesin/gastrin-releasing peptide antagonist RC-3095 impairs inhibitory avoidanceretention. Peptides 2003,24(7):1069–1074. 10.1016/S0196-9781(03)00179-7PubMedView ArticleGoogle Scholar
- Santo-Yamada Y, Yamada K, Wada E, Goto Y, Wada K: Blockade of bombesin-like peptide receptors impairs inhibitory avoidance learning in mice. Neurosci Lett 2003,340(1):65–68. 10.1016/S0304-3940(03)00077-6PubMedView ArticleGoogle Scholar
- Venturella R, Lessa D, Luft T, Roozendaal B, Schwartsmann G, Roesler R: Dexamethasone reverses the memory impairment induced by antagonism of hippocampal gastrin-releasing peptide receptors. Peptides 2005,26(5):821–825. 10.1016/j.peptides.2004.12.010PubMedView ArticleGoogle Scholar
- Han CJ, O'Tuathaigh CM, van Trigt L, Quinn JJ, Fanselow MS, Mongeau R, Koch C, Anderson DJ: Trace but not delay fear conditioning requires attention and the anterior cingulate cortex. Proc Natl Acad Sci USA 2003,100(22):13087–13092. 10.1073/pnas.2132313100PubMed CentralPubMedView ArticleGoogle Scholar
- Tang J, Ko S, Ding HK, Qiu CS, Calejesan AA, Zhuo M: Pavlovian fear memory induced by activation in the anterior cingulate cortex. Mol Pain 2005, 1: 6. 10.1186/1744-8069-1-6PubMed CentralPubMedView ArticleGoogle Scholar
- Ross SE, Mardinly AR, McCord AE, Zurawski J, Cohen S, Jung C, Hu L, Mok SI, Shah A, Savner EM, et al.: Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron 65(6):886–898. 10.1016/j.neuron.2010.02.025Google Scholar
- Darsow U, Drzezga A, Frisch M, Munz F, Weilke F, Bartenstein P, Schwaiger M, Ring J: Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Invest Dermatol 2000,115(6):1029–1033. 10.1046/j.1523-1747.2000.00193.xPubMedView ArticleGoogle Scholar
- Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F, Weilke F, Ring J, Schwaiger M, Bartenstein P: Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain 2001,92(1–2):295–305. 10.1016/S0304-3959(01)00271-8PubMedView ArticleGoogle Scholar
- Herde L, Forster C, Strupf M, Handwerker HO: Itch induced by a novel method leads to limbic deactivations a functional MRI study. J Neurophysiol 2007,98(4):2347–2356. 10.1152/jn.00475.2007PubMedView ArticleGoogle Scholar
- Mochizuki H, Sadato N, Saito DN, Toyoda H, Tashiro M, Okamura N, Yanai K: Neural correlates of perceptual difference between itching and pain: a human fMRI study. Neuroimage 2007,36(3):706–717. 10.1016/j.neuroimage.2007.04.003PubMedView ArticleGoogle Scholar
- Mochizuki H, Tashiro M, Kano M, Sakurada Y, Itoh M, Yanai K: Imaging of central itch modulation in the human brain using positron emission tomography. Pain 2003,105(1–2):339–346. 10.1016/S0304-3959(03)00249-5PubMedView ArticleGoogle Scholar
- Valet M, Pfab F, Sprenger T, Woller A, Zimmer C, Behrendt H, Ring J, Darsow U, Tolle TR: Cerebral processing of histamine-induced itch using short-term alternating temperature modulation--an FMRI study. J Invest Dermatol 2008,128(2):426–433.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.